Prevalence of metabolic syndrome increases with the increase in blood levels of gamma glutamyltransferase and alanine aminotransferase in Japanese men and women

Internal Medicine

Volumn 48, Issue 16, 2009, Pages 1343-1350

  Oda, Eiji ^a   Kawai, Ryu ^a   Watanabe, Kenichi ^b   Sukumaran, Vijayakumar ^b  

^a Tachikawa Medical Center   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Alanine aminotransferase; Fatty liver; Gamma glutamyltransferase; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 70349542522     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2094     Document Type: Article

References (28)

1. Kotronen A, Yki-Jarvinen H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 27-38, 2008.
2. Musso G, Gambino R, Bo S, et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31: 562-568, 2008.
3. Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27: 1427-1432, 2004.
4. Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med 25: 523-529, 2008.
5. Andre P, Balkau B, Vol S, Charles MA, Eschwege E. DESIR Study Group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 30: 2355-2361, 2007.
6. Ford ES, Schulze MB, Bergmann MM, Thamer C, Joost H, Boeing H. Liver enzymes and incident diabetes. Findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 31: 1138-1143, 2008.
7. Ruttmann E, Brant LJ, Concin H, et al. -Glutamyltransferase as a risk factor for cardiovascular disease mortality. An epidemiological investigation in a cohort of 163944 Austrian adults. Circulation 112: 2130-2137, 2005.
8. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27: 127-133, 2007.
9. Goessling W, Massaro JM, Vasan RS, et al. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135: 1835-1944, 2008.
10. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease: a 10-year follow-up of the Hoorn Study. Atherosclerosis 191: 391-396, 2007.
11. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
12. Alverti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480, 2006.
13. The ExaminationCommittee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 94: 794-809, 2005 (in Japanese).
14. Paolicchi A, Emdin M, Ghliozeni E, et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 109: 1440, 2004.
15. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. World Health Org, Geneva, 1999.
16. Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
17. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304, 2005.
18. Grundy SM. Does the metabolic syndrome exist? Diabetes Care 29: 1689-1692, 2006.
19. Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabetes Care 29: 1693-1696, 2006.
20. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83: 1237-1247, 2006.
21. Sattar N. Why metabolic syndrome criteria have not made prime time: a view from the clinic. Int J Obes 32 (S2): S30-S34, 2008.
22. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31: 1285-1293, 2008.
23. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004.
24. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 70 797-799, 2007.
25. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51: 1005-1015, 2002.
26. Katagiri H, Yamada T, Oka Y. Adiposity and Cardiovascular Disorders: Disturbance of the Regulatory System Consisting of Humoral and Neuronal Signals. Circ Res 101: 27-39, 2007.
27. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448-1454, 2005.
28. Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006.